[Oral and parenteral forms of aminobisphosphonate].
Kurth
Andreas H
AH
Orthopädische Universitätsklinik Stiftung Friedrichsheim, Sektion orthopädische Onkologie, Knochenstoffwechselerkrankungen und Hämophiliebehandlung, Frankfurt.
D000284:Administration, Oral; D001859:Bone Neoplasms / Q000451:nursing / Q000556:secondary*; D001862:Bone Resorption / Q000188:drug therapy; D001943:Breast Neoplasms / Q000451:nursing*; D015179:Colorectal Neoplasms / Q000451:nursing*; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D000077557:Ibandronic Acid; D007262:Infusions, Intravenous; D010014:Osteolysis / Q000451:nursing*; D013125:Spinal Neoplasms / Q000451:nursing / Q000556:secondary*
D004164:Diphosphonates; C411447:aminomethane diphosphonate; D000077557:Ibandronic Acid